Oaktree Acquisition Corp. II
OACC - Insider Information
Get informed when a big investor buys or sells
+ FollowMarket Cap$272.45M
Close$
Insider Trades
Loading insider trades…
Congress Trades
Loading congress trades…
Share Statistics
| Market cap | $272.45 Million |
|---|---|
| Enterprise Value | - |
| Earnings per Share | $0.3 |
| Beta | -0.04 |
| Outstanding Shares | 19,199,029 |
Return
| Return on Equity | NaN% |
|---|---|
| Return on Assets | NaN% |
| Return on Invested Capital | NaN% |
Valuation & Multiples
| P/E Ratio | 38.01 |
|---|---|
| PEG | -264.16 |
| Price to Sales | - |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | - |
| Enterprise Value to EBIT | - |
| Enterprise Value to Net Income | - |
| Total Debt to Enterprise | - |
| Debt to Equity | - |
Revenue Sources
No data
Last Earnings Call
Report Date
August 12, 2026
EPS Estimate
-
Consensus analyst estimateRevenue Estimate
-
Consensus analyst estimateInstitutional Put/Call Ratio
Compares institutional put options with call options. At 0.00, the ratio is below 1, so institutions hold more calls than puts.
| Put/Call Ratio | 0.00000% |
|---|---|
| Total Calls | - |
| Total Puts | - |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 88.32%▲ 0.28% |
|---|---|
| Total Invested | $181.50M▲ 1.46% |
| Investors Holding | 510% |
About Oaktree Acquisition Corp. II
3 employees
CEO: Zaid Pardesi
Oaktree Acquisition Corp. III Life Sciences does not have significant operations. The company focuses on effecting a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or m...